Danicamtiv
N/A
Report date: 2026/04/29 20:02:18
NME
Base Information
Drug NameDanicamtiv
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[12]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMyokardia IncBristol-Myers Squibb Company
China Registration ClassN/A
Develop Information
Active CompaniesBristol Myers Squibb SrlcompanyKardigan IncSanofi
Inactive CompaniesMyokardia IncBristol-Myers Squibb Company
Active Indications
Inactive Indications